InspireMD, Inc.
(NYSE Amex Equities : NSPR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific Inc.
-0.02%229.961.0%$371.61m
ISRGIntuitive Surgical, Inc.
-0.75%520.992.4%$367.45m
MDTMedtronic PLC
-0.74%89.930.6%$366.35m
ALGNAlign Technology, Inc.
-1.25%352.846.3%$292.05m
ABTAbbott Laboratories
-0.43%64.450.8%$288.94m
ABMDABIOMED, Inc.
0.26%359.743.3%$251.35m
BSXBoston Scientific Corporation
-0.61%34.201.1%$243.29m
BDXBecton, Dickinson and Company
-0.15%252.731.1%$238.14m
BAXBaxter International Inc.
-0.08%71.981.7%$228.00m
SYKStryker Corporation
-0.67%168.841.3%$219.13m
EWEdwards Lifesciences Corporation
-0.12%139.601.2%$187.54m
DXCMDexCom, Inc.
0.16%131.178.6%$162.79m
ZBHZimmer Biomet Holdings, Inc.
0.41%124.371.7%$148.56m
XRAYDENTSPLY International Inc.
-0.39%38.523.0%$136.60m
IDXXIDEXX Laboratories, Inc.
-1.08%240.883.7%$107.42m

Company Profile

InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.